Attenuation of the suppressive activity of cellular splicing factor SRSF3 by Kaposi sarcoma-associated herpesvirus ORF57 protein is required for RNA splicing

RNA

Volumn 20, Issue 11, 2014, Pages 1747-1758

  Majerciak, Vladimir ^a   Lu, Mathew ^a   Li, Xiaofan ^a   Zheng, Zhi Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Alternative splicing; KSHV; ORF57; RNA processing; SRSF3

Indexed keywords

ORF57 PROTEIN; RNA BINDING PROTEIN; SERINE ARGININE RICH PROTEIN; SERINE ARGININE RICH SPLICING FACTOR 3; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; K8 PROTEIN, HUMAN HERPESVIRUS 8; REPRESSOR PROTEIN; SRSF3 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING AFFINITY; BOVINE PAPILLOMAVIRUS TYPE 1; CELL LYSATE; CONTROLLED STUDY; CROSS LINKING; EXPRESSION VECTOR; FEMALE; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOPRECIPITATION; INTRON; KAPOSI SARCOMA; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOP CODON; TRANSIENT EXPRESSION; VIRUS ATTENUATION; VIRUS GENOME; WESTERN BLOTTING; BINDING SITE; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; RNA SPLICING;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BINDING SITES; HEK293 CELLS; HELA CELLS; HERPESVIRUS 8, HUMAN; HUMANS; INTRONS; REPRESSOR PROTEINS; RNA SPLICING; RNA, VIRAL; RNA-BINDING PROTEINS; VIRAL PROTEINS;

EID: 84908130097     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.045500.114     Document Type: Article

References (59)

1. Auyeung VC, Ulitsky I, McGeary SE, Bartel DP. 2013. Beyond secondary structure: Primary-sequence determinants license pri-miRNA hairpins for processing. Cell 152: 844-858.
2. Boyne JR, Colgan KJ, Whitehouse A. 2008. Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication. PLoS Pathog 4: E1000194.
3. Boyne JR, Jackson BR, Taylor A, Macnab SA, Whitehouse A. 2010. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs. EMBO J 29: 1851-1864.
4. Caceres JF, Krainer AR. 1993. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. EMBO J 12: 4715-4726.
5. Caceres JF, Misteli T, Screaton GR, Spector DL, Krainer AR. 1997. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol 138: 225-238.
6. Corbo C, Orru S, Gemei M, Noto RD, Mirabelli P, Imperlini E, Ruoppolo M, Vecchio LD, Salvatore F. 2012. Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity. Proteomics 12: 2045-2059.
7. Escudero-Paunetto L, Li L, Hernandez FP, Sandri-Goldin RM. 2010. SR proteins SRp20 and 9G8 contribute to efficient export of herpes simplex virus 1 mRNAs. Virology 401: 155-164.
8. Franzosa EA, Xia Y. 2011. Structural principles within the human-virus protein-protein interaction network. Proc Natl Acad Sci 108: 10538-10543.
9. Galiana-Arnoux D, Lejeune F, Gesnel MC, Stevenin J, Breathnach R, Del Gatto-Konczak F. 2003. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20. J Biol Chem 278: 32943-32953.
10. Guito J, Lukac DM. 2012. KSHV Rta promoter specification and viral reactivation. Front Microbiol 3: 30.
11. Gupta AK, Ruvolo V, Patterson C, Swaminathan S. 2000. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. J Virol 74: 1038-1044.
12. Han Z, Swaminathan S. 2006. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J Virol 80: 5251-5260.
13. Hardy WR, Sandri-Goldin RM. 1994. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J Virol 68: 7790-7799.
14. He X, Arslan AD, Pool MD, Ho TT, Darcy KM, Coon JS, Beck WT. 2011. Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene 30: 356-365.
15. Hiriart E, Gruffat H, Buisson M, Mikaelian I, Keppler S, Meresse P, Mercher T, Bernard OA, Sergeant A, Manet E. 2005. Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export. J Biol Chem 280: 36935-36945.
16. Huang Y, Steitz JA. 2001. Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol Cell 7: 899-905.
17. Iborra S, Hirschfeld M, Jaeger M, Zur HA, Braicu I, Sehouli J, Gitsch G, Stickeler E. 2013. Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact. Int J Gynecol Cancer 23: 990-996.
18. Jia R, Zheng ZM. 2012. SRSF3 (serine/arginine-rich splicing factor 3). Atlas Genet Cytogenet Oncol Haematol. http://AtlasGeneticsOncology.org/Genes/SRSF3ID42279ch6p21.html.
19. Jia R, Liu X, Tao M, Kruhlak M, Guo M, Meyers C, Baker CC, Zheng ZM. 2009. Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol 83: 167-180.
20. Jia R, Li C, McCoy JP, Deng CX, Zheng ZM. 2010. SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci 6: 806-826.
21. Juillard F, Bazot Q, Mure F, Tafforeau L, Macri C, Rabourdin-Combe C, Lotteau V, Manet E, Gruffat H. 2012. Epstein-Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAs. Nucleic Acids Res 40: 6834-6849.
22. Jumaa H, Nielsen PJ. 1997. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J 16: 5077-5085.
23. Jumaa H, Wei G, Nielsen PJ. 1999. Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr Biol 9: 899-902.
24. Kang JG, Pripuzova N, Majerciak V, Kruhlak M, Le SY, Zheng ZM. 2011. Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J Virol 85: 2620-2630.
25. Kiel C, Verschueren E, Yang JS, Serrano L. 2013. Integration of protein abundance and structure data reveals competition in the ErbB signaling network. Sci Signal 6: ra109.
26. Kirshner JR, Lukac DM, Chang J, Ganem D. 2000. Kaposi's sarcomaassociated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol 74: 3586-3597.
27. Lindtner S, Zolotukhin AS, Uranishi H, Bear J, Kulkarni V, Smulevitch S, Samiotaki M, Panayotou G, Felber BK, Pavlakis GN. 2006. RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway. J Biol Chem 281: 36915-36928.
28. Liu X, Mayeda A, Tao M, Zheng ZM. 2003. Exonic splicing enhancerdependent selection of the bovine papillomavirus type 1 nucleotide 3225 3′ splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway. J Virol 77: 2105-2115.
29. Loomis RJ, Naoe Y, Parker JB, Savic V, Bozovsky MR, Macfarlan T, Manley JL, Chakravarti D. 2009. Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation. Mol Cell 33: 450-461.
30. Lou H, Neugebauer KM, Gagel RF, Berget SM. 1998. Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol Cell Biol 18: 4977-4985.
31. Maciolek NL, McNally MT. 2007. Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in Rous sarcoma virus. J Virol 81: 11208-11217.
32. Majerciak V, Zheng ZM. 2009. Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing. Front Biosci 14: 1516-1528.
33. Majerciak V, Yamanegi K, Nie SH, Zheng ZM. 2006. Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J Biol Chem 281: 28365-28378.
34. Majerciak V, Pripuzova N, McCoy JP, Gao SJ, Zheng ZM. 2007. Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8α, and K8.1 and the production of infectious virus. J Virol 81: 1062-1071.
35. Majerciak V, Yamanegi K, Allemand E, Kruhlak M, Krainer AR, Zheng ZM. 2008. Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron- containing viral lytic genes in spliceosome-mediated RNA splicing. J Virol 82: 2792-2801.
36. Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM. 2011. Kaposi's sarcoma- Associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol 85: 1528-1540.
37. Malik P, Clements JB. 2004. Protein kinase CK2 phosphorylation regulates the interaction of Kaposi's sarcoma-associated herpesvirus regulatory protein ORF57 with its multifunctional partner hnRNP K. Nucleic Acids Res 32: 5553-5569.
38. Malik P, Blackbourn DJ, Clements JB. 2004. The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor. J Biol Chem 279: 33001-33011.
39. Manley JL, Krainer AR. 2010. A rational nomenclature for serine/arginine- rich protein splicing factors (SR proteins). Genes Dev 24: 1073-1074.
40. Massimelli MJ, Kang JG, Majerciak V, Le SY, Liewehr DJ, Steinberg SM, Zheng ZM. 2011. Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5′ end to interact with viral ORF57 and cellular PABPC1. Int J Biol Sci 7: 1145-1160.
41. Massimelli MJ, Majerciak V, Kruhlak M, Zheng ZM. 2013. Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA. J Virol 87: 243-256.
42. Moriuchi H, Moriuchi M, Smith HA, Cohen JI. 1994. Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. J Virol 68: 1987-1992.
43. Nekorchuk M, Han Z, Hsieh TT, Swaminathan S. 2007. Kaposi's sarcoma- Associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export. J Virol 81: 9990-9998.
44. Ote I, Lebrun M, Vandevenne P, Bontems S, Medina-Palazon C, Manet E, Piette J, Sadzot-Delvaux C. 2009. Varicella-zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway. PLoS One 4: E7882.
45. Pilkington GR, Majerciak V, Bear J, Uranishi H, Zheng ZM, Felber BK. 2012. Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor. J Virol 86: 13089-13094.
46. Renne R, Zhong W, Herndier B, McGrath M, Abbey B, Kedes D, Ganem D. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2: 342-346.
47. Saeki K, Yasugi E, Okuma E, Breit SN, Nakamura M, Toda T, Kaburagi Y, Yuo A. 2005. Proteomic analysis on insulin signaling in human hematopoietic cells: Identification of CLIC1 and SRp20 as novel downstream effectors of insulin. Am J Physiol Endocrinol Metab 289: E419-E428.
48. Sciabica KS, Dai QJ, Sandri-Goldin RM. 2003. ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J 22: 1608-1619.
49. Sen S, Talukdar I, Webster NJ. 2009. SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing. Mol Cell Biol 29: 871-880.
50. Sen S, Jumaa H, Webster NJ. 2013. Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function. Nat Commun 4: 1336.
51. Tang S, Zheng ZM. 2002. Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5′-splice sites and harbors a K8.1 transcription start site. J Biol Chem 277: 14547-14556.
52. Uranishi H, Zolotukhin AS, Lindtner S, Warming S, Zhang GM, Bear J, Copeland NG, Jenkins NA, Pavlakis GN, Felber BK. 2009. The RNA binding motif protein 15B (RBM15B/OTT3) acts as cofactor of the nuclear export receptor NXF1. J Biol Chem 284: 26106-26116.
53. Verma D, Swaminathan S. 2008. Epstein-Barr virus SM protein functions as an alternative splicing factor. J Virol 82: 7180-7188.
54. Verma D, Bais S, Gaillard M, Swaminathan S. 2010. Epstein-Barr virus SM protein utilizes cellular splicing factor SRp20 to mediate alternative splicing. J Virol 84: 11781-11789.
55. Watanuki T, Funato H, Uchida S, Matsubara T, Kobayashi A, Wakabayashi Y, Otsuki K, Nishida A, Watanabe Y. 2008. Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients. J Affect Disord 110: 62-69.
56. Wong J, Garner B, Halliday GM, Kwok JB. 2012. Srp20 regulates TrkB pre-mRNA splicing to generate TrkB-Shc transcripts with implications for Alzheimer's disease. J Neurochem 123: 159-171.
57. Yamanegi K, Tang S, Zheng ZM. 2005. Kaposi's sarcoma-associated herpesvirus K8β is derived from a spliced intermediate of K8 pre-mRNA and antagonizes K8α (K-bZIP) to induce p21 and p53 and blocks K8α-CDK2 interaction. J Virol 79: 14207-14221.
58. Zahler AM, Lane WS, Stolk JA, Roth MB. 1992. SR proteins: A conserved family of pre-mRNA splicing factors. Genes Dev 6: 837-847.
59. Zhou Z, Licklider LJ, Gygi SP, Reed R. 2002. Comprehensive proteomic analysis of the human spliceosome. Nature 419: 182-185.